Transcriptomic Signatures in Neuroendocrine Cell Hyperplasia of Infancy (NEHI)

Awardee: Sharon McGrath-Morrow

Institution: Children's Hospital of Philadelphia

Grant Amount: $83,154

Funding Period: February 1, 2025 - January 31, 2026


Summary:

Our research has the potential to significantly improve NEHI diagnosis, enhance our understanding of disease pathogenesis, and lay the groundwork for targeted therapeutic interventions.

Previous
Previous

Tcf4 in gut development; investigating underlying causes of gastro-intestinal problems in patients with Pitt Hopkins syndrome

Next
Next

Bronchoalveolar Lavage Fluid-Derived Organoids as Translational Models for Neuroendocrine cell hyperplasia of infancy